In this series, we bring together the foremost medical experts to enlighten and empower women facing a diagnosis of HR+/HER2- metastatic breast cancer. They provide answers to your top questions and share insights and practical tips that help you move ahead with clarity and confidence.
Yale oncologist Maryam Lustberg, MD, describes metastatic breast cancer, with a special focus on HR+/HER2-, which accounts for 70% of all breast cancers.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.